Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ketamine As Adjuvant to Bupivacaine in Ultrasound Guided Quadratus Lumborum Block for Infants Undergoing Open Pyeloplasty

NCT07596810 is registered in ClinicalTrials.gov with Alexandria University as lead sponsor.

NCT NCT07596810
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07596810 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ketamine As Adjuvant to Bupivacaine in Ultrasound Guided Quadratus Lumborum Block for Infants Undergoing Open Pyeloplasty
Lead sponsor
Alexandria University
Phase
Phase 4
Overall status
Completed
Start date
June 1, 2025
Completion date
February 1, 2026
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

postoperative pain, ureteropelvic junction obstruction